The Bonds’ debut in the Philippines will be followed by further commercialization through of 2022.Read More
Tags :Philip Morris International
PMI will pay Altria Group nearly $2.7 billion for exclusive U.S. commercialization rights to IQOS.Read More
The ITC should have consulted more with the FDA prior to banning the device, say PMI lawyers. Read More
The verdict concerns counterclaims in RJR’s ongoing lawsuit over PMI’s IQOS device.Read More
Reports claim Australian pharmacists would receive AUD275 ($190.24) for ordering Veev vapes.Read More
The move follows a development and distribution agreement between the two companies.Read More
A federal court jury said RJR's Vuse Solo and Alto devices infringe two Philip Morris patents.Read More
The deal allows Philip Morris Products to manufacture, promote and sell the Bidi Stick outside of the U.S.Read More
Because device is similar to the previous version, PMI can make the same exposure reduction claims. Read More
A design change, however, would require re-authorization from the U.S. Food and Drug Administration.Read More
